Cardinal Health Reports Strong Q4 and FY2026 Results, Provides FY2027 Outlook

Details

The company's GAAP diluted EPS for the fourth quarter increased 70% to $1.70, and non-GAAP diluted EPS increased 40% to $2.91. For fiscal year 2026, GAAP diluted EPS increased 12% to $7.23, and non-GAAP diluted EPS increased 37% to $11.26. The company also provided fiscal year 2027 non-GAAP EPS guidance of $12.40 to $12.60, indicating 13% to 15% growth. Additionally, Cardinal Health completed a $350 million share repurchase and approved a $5.0 billion increase to the share repurchase program.

Items reported

About Cardinal Health Inc.

Cardinal Health Inc. is a major global healthcare services and products company, distinguished for providing end-to-end medical solutions. Specializing in healthcare distribution and supply chain management, Cardinal Health serves a comprehensive array of clients including hospitals, pharmacies, and healthcare providers. Notably, the company distributes pharmaceuticals, medical products, and laboratory supplies, ensuring efficient delivery to improve healthcare outcomes. Based in Dublin, Ohio, Cardinal Health plays a pivotal role in enhancing healthcare operational efficiency, offering extensive services like inventory management, logistics optimization, and integrated healthcare solutions that empower providers to focus on patient care. As one of the largest pharmaceutical distributors in the United States, it holds substantial influence in the healthcare sector, pivotal in ensuring the availability of drugs and medical supplies across various platforms, contributing significantly to the healthcare infrastructure worldwide.